Cargando…
The antisecretory peptide AF-16 may modulate tissue edema but not inflammation in experimental peritonitis induced sepsis
Sepsis is a life-threatening condition due to a dysregulated immunological response to infection. Apart from source control and broad-spectrum antibiotics, management is based on fluid resuscitation and vasoactive drugs. Fluid resuscitation implicates the risk of volume overload, which in turn is as...
Autores principales: | Barrueta Tenhunen, Annelie, van der Heijden, Jaap, Blokhin, Ivan, Massaro, Fabrizia, Hansson, Hans Arne, Feinstein, Ricardo, Larsson, Anders, Tenhunen, Jyrki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446908/ https://www.ncbi.nlm.nih.gov/pubmed/32822373 http://dx.doi.org/10.1371/journal.pone.0232302 |
Ejemplares similares
-
Does the antisecretory peptide AF-16 reduce lung oedema in experimental
ARDS?
por: Barrueta Tenhunen, Annelie, et al.
Publicado: (2019) -
Fluid restrictive resuscitation with high molecular weight hyaluronan infusion in early peritonitis sepsis
por: Tenhunen, Annelie Barrueta, et al.
Publicado: (2023) -
HIGH-MOLECULAR-WEIGHT HYALURONAN—A POTENTIAL ADJUVANT TO FLUID RESUSCITATION IN ABDOMINAL SEPSIS?
por: Barrueta Tenhunen, Annelie, et al.
Publicado: (2023) -
Intranasal Administration of the Antisecretory Peptide AF-16 Reduces Edema and Improves Cognitive Function Following Diffuse Traumatic Brain Injury in the Rat
por: Clausen, Fredrik, et al.
Publicado: (2017) -
Plasma hyaluronan, hyaluronidase activity and endogenous hyaluronidase inhibition in sepsis: an experimental and clinical cohort study
por: van der Heijden, Jaap, et al.
Publicado: (2021)